Traders Rotate Out of Biotech after Month Long Rally (XBI) (INCY) (REGN)

July 11, 2012 1:31 PM EDT
Shares of Incyte Genomics, Inc. (Nasdaq: INCY) are trading lower by 6 percent today. Incyte Corporation, a biopharmaceutical company, focuses the development and commercialization of proprietary small molecule drugs for oncology.

Shares of Incyte are up 61.5 percent year-to-date, and considering low volumes, traders say the selloff is tied to profit taking in biotech stocks today.

Shares of Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) are also trading lower. SPDR S&P Biotech, (NYSE: XBI) which owns both of these high fliers, is lower by 2.4 percent. XBI is up 14.3 percent in the past 30 days.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

Standard & Poor's

Add Your Comment